Follicunodis en es it fr

Follicunodis Brand names, Follicunodis Analogs

Follicunodis Brand Names Mixture

  • Cimicifuga Plex (Caulophyllum Thalictroides + Cimicifuga Racemosa + Copper + Cotton Plant + Estrone + Histamine Dihydrochloride + Hypothalamus + Magnesium Phosphate Dibasic + Pituitary Whole + Platinum + Sepia Officinalis L + Thyroid)
  • Holis 98 (Dioscorea Vilosa + Estrone + Salvia + Saw Palmetto)

Follicunodis Chemical_Formula


Follicunodis RX_link

No information avaliable

Follicunodis fda sheet

Follicunodis msds (material safety sheet)

Follicunodis MSDS

Follicunodis Synthesis Reference

G. Anner, K. Miescher, and Helv. Chem. Acta. 31, 2173(1948)

Follicunodis Molecular Weight

270.366 g/mol

Follicunodis Melting Point

254.5-256 oC

Follicunodis H2O Solubility

3 g/100mL

Follicunodis State


Follicunodis LogP


Follicunodis Dosage Forms

Vaginal cream; Vaginal suppository; Patch; Skin gel; Tablet; IM injectable suspension

Follicunodis Indication

For management of Menopausal and postmenopausal disorders

Follicunodis Pharmacology

Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. Estropipate is piperazine-stabilized estrone sulfate. Estrone, and estropipate are used to treat abnormalities related to gonadotropin hormone dysfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy associated with menopause, and for the prevention of osteoporosis due to estrogen deficiency.

Follicunodis Absorption


Follicunodis side effects and Toxicity

Symptoms of overdose include nausea and vomiting. Withdrawal bleeding may occur in females.

Follicunodis Patient Information

Follicunodis Organisms Affected

Humans and other mammals